Rain Therapeutics Inc. (RAIN) Misses Q2 EPS by 10c

Rain Therapeutics Inc. (NASDAQ: RAIN) reported Q2 EPS of ($0.61), $0.10 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Rain Therapeutics Inc. (RAIN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• MotorK names Roy Toren to board as Helen Protopapas resigns
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies